289
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Enhanced dissolution of sildenafil citrate as dry foam tablets

, , , &
Pages 1-11 | Received 17 Jul 2016, Accepted 09 Dec 2016, Published online: 30 Jan 2017

References

  • ASEAN Guideline on Stability of Drug Products. 2013. Available from: http://www.hsa.gov.sg/content/dam/HSA/HPRG/Western_Medicine/Overview_Framework_Policies/Guidelines_on_Drug_Registration/ASEAN%20STABILITY%20GUIDELINE%20(version%206.0).pdf
  • Bajaj S, Singla D, Sakhuja N. 2012. Stability testing of pharmaceutical products. J App Pharm Sci. 2:129–138.
  • Chocalingam A, Gnanavelu G, Venkatesan S, Elangovan S, Jagannathan V, Subramaniam T, Alagesan R, Dorairajan S. 2005. Efficacy and optimal dose of sildenafil in primary pulmonary hypertension. Int J Cardiol. 99:91–95.
  • Dischinger A, Page S, Kleinebudde P. 2015. Fast dissolving fillers in dry foam formulation. Powder Technol. 270:494–501.
  • Ghofrani HA, Osterloh IH, Grimminger F. 2006. Sildenafil: from angina to erectile dysfunction to pulmonary hypertension and beyond. Nat Rev Drug Discov. 5:689–702.
  • Hirani JJ, Rathod DA, Vadalia KR. 2009. Orally disintegrating tablets: a review. Trop J Pharm Res. 2009;8:161–172.
  • Júlio TA, Zâmara IF, Garcia JS, Trevisan MG. 2013. Compatibility of sildenafil citrate and pharmaceutical excipients by thermal analysis and LC-UV. J Chem Anal Calorim. 111:2037–2044.
  • Jung S, Seo Y, Kim GK, Woo JS, Yong CS, Choi HG. 2011. Comparison of the solubility and pharmacokinetics of sildenafil salts. Arch Pharm Res. 34:451–454.
  • Lenz E, Sprunk A, Kleinebudde P, Page S. 2015. Impact of fillers on dissolution kinetic of fenofibrate dry foams. Pharm Dev Technol. 20:570–578.
  • Magdassi S, Kamyshny A, Margulis-Goshen K. 2008. Application of surfactants in pharmaceutical dosage forms. In: Zoller U, editor. Handbook of detergents. Boca Raton, FL: CRC Press; p. 455–468.
  • Patel H, Panchal MS, Shah S, Vadalia KR. 2012. Formulation and evaluation of transdermal gel of sildenafil citrate. Int J Pharm Res & All Sci. 3:103–118.
  • Pfizer Inc., USA. 2010. Package insert of Viagra tablets. Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020895s033lbl.pdf.
  • Pfizer Inc., USA. 2015. Material safety data sheet, Sildenafil citrate orally disintegrating tablet. [cited 2015 April 6]. Available from: http://www.pfizer.com/system/files/products/material_safety_data/Sildenafil_orally_disintegrating_tablet_6-apr-2015.pdf
  • Ramirez E, Laosa O, Guerra P, Duque B, Mosquera B, Borobia AM, Lei SH, Carcas AJ, Frias J. 2010. Acceptability and characteristics of 124 human bioequivalence studies with active substances classified according to the biopharmaceutic classification system. Br J Clin Pharmacol. 70:694–702.
  • Sandhya V, Ram NS, Rao VU. 2012. Determination of effect of magnesium stearate on sildenafil citrate tablets. Int J Adv Pharm. 2:1–4.
  • Sawatdee S, Atipairin A, Sae Yoon A, Srichana T. 2016. Enhanced dissolution of sildenafil dry foam tablet. Asian J Pharm Sci. 11:191–192.
  • Sawatdee S, Hiranphan P, Laphanayos K, Srichana T. 2014. Evaluation of sildenafil pressurized metered dose inhalers as a vasodilator in umbilical blood vessels of chicken egg embryos. Eur J Pharm Biopharm. 86:90–97.
  • Sawatdee S, Phetmung H, Srichana T. 2013. Sildenafil citrate monohydrate–cyclodextrin nanosuspension complexes for use in metered-dose inhalers. Int J Pharm. 455:248–258.
  • Sawatdee S, Srichana T. 2013. Analytical validation of sildenafil citrate inhaler preparation. Chiang Mai J Sci. 40:669–680.
  • Sivakranth M, Althaf AS, Rajasekhar S. 2011. Formulation and evaluation of oral fast dissolving tablets of sildenafil citrate. Int J Pharm Pharm Sci. 3:112–121.
  • Sprunk A, Page S, Kleinebudde P. 2013. Influence of process parameters and equipment on dry foam formulation properties using indomethacin as model drug. Int J Pharm. 455:189–196.
  • Thompson MR, Weatherley S, Pukadyil RN, Sheskey PJ. 2012. Foam granulation: new developments in pharmaceutical solid oral dosage forms using twin screw extrusion machinery. Drug Dev Ind Pharm. 38:771–784.
  • United States Pharmacopeial Convention. 2012. USP36 NF31, US Pharmacopoeia National Formulary.
  • Yonessi M, Saeedi M. 2005. A double-blind placebo-controlled evaluation of effect of topical sildenafil on erectile dysfunction. J Appl Res. 5:289–294.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.